Custodio JM - Search Results

1

ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision.

Zamek-Gliszczynski MJ, Chu X, Cook JA, Custodio JM, Galetin A, Giacomini KM, Lee CA, Paine MF, Ray AS, Ware JA, Wittwer MB, Zhang L; International Transporter Consortium. Zamek-Gliszczynski MJ, et al. Among authors: custodio jm. Clin Pharmacol Ther. 2018 Nov;104(5):781-784. doi: 10.1002/cpt.1082. Epub 2018 May 15. Clin Pharmacol Ther. 2018. PMID: 29761830

2

Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.

Custodio JM, Yin X, Hepner M, Ling KH, Cheng A, Kearney BP, Ramanathan S. Custodio JM, et al. J Clin Pharmacol. 2014 Apr;54(4):378-85. doi: 10.1002/jcph.210. Epub 2013 Nov 16. J Clin Pharmacol. 2014. PMID: 24142299 Clinical Trial.

3

Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin.

Custodio JM, Wang H, Hao J, Lepist EI, Ray AS, Andrews J, Ling KH, Cheng A, Kearney BP, Ramanathan S. Custodio JM, et al. J Clin Pharmacol. 2014 Jun;54(6):649-56. doi: 10.1002/jcph.256. Epub 2014 Jan 17. J Clin Pharmacol. 2014. PMID: 24375014 Clinical Trial.

4

Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Custodio JM, Wu CY, Benet LZ. Custodio JM, et al. Adv Drug Deliv Rev. 2008 Mar 17;60(6):717-33. doi: 10.1016/j.addr.2007.08.043. Epub 2007 Nov 28. Adv Drug Deliv Rev. 2008. PMID: 18199522 Free PMC article. Review.

5

Pharmacokinetics and safety of boosted elvitegravir in subjects with hepatic impairment.

Custodio JM, Rhee M, Shen G, Ling KH, Kearney BP, Ramanathan S. Custodio JM, et al. Antimicrob Agents Chemother. 2014 May;58(5):2564-9. doi: 10.1128/AAC.02180-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550332 Free PMC article. Clinical Trial.

6

Population Pharmacokinetics of Boosted-Elvitegravir in HIV-Infected Patients.

Custodio JM, Gordi T, Zhong L, Ling KH, Ramanathan S. Custodio JM, et al. J Clin Pharmacol. 2016 Jun;56(6):723-32. doi: 10.1002/jcph.657. Epub 2015 Dec 21. J Clin Pharmacol. 2016. PMID: 26449283 Clinical Trial.

7

Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir.

Nguyen T, McNicholl I, Custodio JM, Szwarcberg J, Piontkowsky D. Nguyen T, et al. Among authors: custodio jm. AIDS Rev. 2016 Apr-Jun;18(2):101-11. AIDS Rev. 2016. PMID: 27196356 Review.

8

Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide.

Custodio JM, Chuck SK, Chu H, Cao H, Ma G, Flaherty J, Ling J, Kearney BP. Custodio JM, et al. Pharmacol Res Perspect. 2017 Oct;5(5):e00353. doi: 10.1002/prp2.353. Pharmacol Res Perspect. 2017. PMID: 28971607 Free PMC article. Clinical Trial.

9

Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals.

Begley R, Das M, Zhong L, Ling J, Kearney BP, Custodio JM. Begley R, et al. Among authors: custodio jm. J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):465-472. doi: 10.1097/QAI.0000000000001699. J Acquir Immune Defic Syndr. 2018. PMID: 29649076

10

An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes.

Custodio JM, Donaldson KM, Hunt HJ. Custodio JM, et al. J Clin Pharmacol. 2021 Feb;61(2):244-253. doi: 10.1002/jcph.1731. Epub 2020 Aug 31. J Clin Pharmacol. 2021. PMID: 32869328 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page